Literature DB >> 12021494

Human mesenchymal stem cells: insights from a surrogate in vivo assay system.

Tippi C MacKenzie1, Alan W Flake.   

Abstract

Mesenchymal stem cells (MSC) are multipotent cells that have been isolated from the bone marrow of multiple species that can be induced to differentiate into at least bone, cartilage, and adipose tissue in vitro. Using a model of in utero cellular transplantation in which human MSC are transplanted into fetal lambs, we have shown that MSC can engraft in multiple tissues and persist for over one year. Furthermore, these cells can differentiate into cardiac and skeletal myocytes, bone marrow stromal cells, adipocytes, thymic epithelial cells, and chondrocytes. These observations lend support to the potential utility of MSC for cellular and/or gene therapy in the treatment of a variety of congenital or acquired diseases such as osteogenesis imperfecta, muscular dystrophy, lysosomal storage diseases, and for enhancement of bone marrow transplantation. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12021494     DOI: 10.1159/000057694

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  6 in total

Review 1.  Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage.

Authors:  W R Otto; J Rao
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

2.  Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes.

Authors:  L Zazzeroni; G Lanzoni; G Pasquinelli; C Ricordi
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2017-09-29

Review 3.  Stem celltherapy for ischemic heart failure.

Authors:  Doreen Rosenstrauch; Gregor Poglajen; Nina Zidar; Igor D Gregoric
Journal:  Tex Heart Inst J       Date:  2005

4.  Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation.

Authors:  Yong Li; Dingguo Zhang; Yuqing Zhang; Guoping He; Fumin Zhang
Journal:  J Biomed Sci       Date:  2010-09-17       Impact factor: 8.410

Review 5.  Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy.

Authors:  Jinglian Yan; Guodong Tie; Ting Yu Xu; Katharine Cecchini; Louis M Messina
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 6.  In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases.

Authors:  Neeladri Chowdhury; Atsushi Asakura
Journal:  Stem Cells Int       Date:  2017-05-15       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.